Role of hematological parameters in the stratification of COVID-19 disease severity

Terpos, 2020, Hematological findings and complications of COVID‐19, Am. J. Hematol., 95, 834, 10.1002/ajh.25829 Mehta, 2020, COVID-19: consider cytokine storm syndromes and immunosuppression, Lancet (London, England), 395, 1033, 10.1016/S0140-6736(20)30628-0 Tang, 2020, Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia, J. Thromb. Haemostasis, 18, 844, 10.1111/jth.14768 Shang, 2020, Management of critically ill patients with COVID-19 in ICU: statement from front-line intensive care experts in Wuhan, China, Ann. Intensive Care, 10, 1, 10.1186/s13613-020-00689-1 Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, The lancet, 395, 497, 10.1016/S0140-6736(20)30183-5 Lillicrap, 2020, Disseminated intravascular coagulation in patients with 2019‐nCoV pneumonia, J. Thromb. Haemostasis, 18, 786, 10.1111/jth.14781 Lippi, 2020, Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis, Clin. Chim. Acta, 506, 145, 10.1016/j.cca.2020.03.022 Amgalan, 2020, Hemostatic laboratory derangements in COVID-19 with a focus on platelet count, Platelets, 1 Jin, 2020, Gender differences in patients with COVID-19: focus on severity and mortality, Front. Publ. Health, 8, 152, 10.3389/fpubh.2020.00152 Liao, 2020, Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study, Lancet Haematol., 7, e671, 10.1016/S2352-3026(20)30217-9 Yang, 2020, The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients, Int. Immunopharm., 106504, 10.1016/j.intimp.2020.106504 Fan, 2020, Hematologic parameters in patients with COVID‐19 infection, Am. J. Hematol., 95, E131, 10.1002/ajh.25774 Bansal, 2020 Iba, 2020, Coagulopathy in COVID‐19, J. Thromb. Haemostasis, 18, 2103, 10.1111/jth.14975 Imran, 2020, Association of plasma CRP level with the severity of COVID-19, Int. J. Sci., 9, 20 Mehra, 2020, Cardiovascular disease, drug therapy, and mortality in COVID-19, N. Engl. J. Med., 382, e102, 10.1056/NEJMoa2007621 Albiol, 2020, Autoimmune thrombotic thrombocytopenic purpura (TTP) associated with COVID-19, Ann. Hematol., 1